Webcast Alert: Heska Announces Second Quarter 2016 Earnings Conference Call Webcast
PR Newswire - Fri Jul 29, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 43.41 (+0.86)
Strength Seen in Heska (HSKA): Stock Jumps 5.7% in Session
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:35AM CDT
Heska Corporation (HSKA) was a big mover last session, as the company saw its shares rise around 6% on the day.
HSKA: 43.41 (+0.86), ENZ: 6.72 (-0.25)
Heska (HSKA) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Heska Corporation (HSKA) has been struggling lately, but the selling pressure may be coming to an end soon
HSKA: 43.41 (+0.86)
New Strong Buy Stocks for June 2nd
Swarup Gupta - ZACKS - Thu Jun 02, 8:30AM CDT
New Strong Buy Stocks for June 2nd
HSKA: 43.41 (+0.86), FMBH: 24.22 (-0.97), DISCA: 24.77 (-0.32), LXFR: 11.98 (-0.12), BNS: 49.96 (-0.81)
Galena Biopharma (GALE) in Focus: Stock Moves Up 19.3%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:15AM CDT
Galena Biopharma, Inc. (GALE) shares rose over 19% in the last trading session.
HSKA: 43.41 (+0.86), GALE: 0.45 (+0.01)
Edge Therapeutics (EDGE) Catches Eye: Stock Soars 19.4%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:00AM CDT
Edge Therapeutics, Inc (EDGE) was a big mover last session, as the company's shares rose over 19% on the day.
HSKA: 43.41 (+0.86), EDGE: 9.63 (-0.07)
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 84.59 (+0.32), HSKA: 43.41 (+0.86), ANIP: 61.06 (+0.46), NEO: 8.52 (-0.20)
Acorda Shelves Development of Epilepsy Treatment, Plumiaz
Arpita Dutt - Zacks Investment Research - Mon May 23, 6:39AM CDT
Acorda's (ACOR) decision to terminate the development of Plumiaz was based on data from ongoing studies.
HSKA: 43.41 (+0.86), ANIP: 61.06 (+0.46), RTRX: 18.17 (+0.24), ACOR: 25.13 (-0.15)
The Zacks Analyst Blog Highlights: B&G, Dean Foods, Richmont Mines, Chesapeake Utilities and Heska
Zacks Equity Research - Zacks Investment Research - Wed May 18, 8:30AM CDT
The Zacks Analyst Blog Highlights: B&G, Dean Foods, Richmont Mines, Chesapeake Utilities and Heska
CPK: 63.97 (-0.10), HSKA: 43.41 (+0.86), BGS: 51.54 (-0.05), RIC: 11.22 (+0.10), DF: 18.89 (+0.43)
Dodge Market Volatility with These 5 Low-Beta Stocks
Zacks Equity Research - Zacks Investment Research - Tue May 17, 10:29AM CDT
For a long-term investor, it's always safer to invest in low-risk stocks.
CPK: 63.97 (-0.10), HSKA: 43.41 (+0.86), RIC: 11.22 (+0.10), DF: 18.89 (+0.43)
BioDelivery-Collegium Collaborate for Onsolis in U.S.
Zacks Equity Research - Zacks Investment Research - Thu May 12, 4:34PM CDT
BioDelivery Sciences (BDSI) and Collegium Pharmaceutical, have entered into a licensing deal for Onsolis in the U.S.
BDSI: 2.41 (-0.14), HSKA: 43.41 (+0.86), ANIP: 61.06 (+0.46), COLL: 11.86 (-0.27)
Heska to Present at Stifel Dental & Veterinary Conference
PR Newswire - Thu May 12, 3:30PM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
HSKA: 43.41 (+0.86)
Is Heska Corporation (HSKA) a Great Growth Stock?
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:51AM CDT
Heska Corporation (HSKA) looks like an exciting pick for investors as it is poised for strong future growth.
HSKA: 43.41 (+0.86)
Kite Pharma (KITE) Posts Narrower-than-Expected Loss in Q1
Arpita Dutt - Zacks Investment Research - Tue May 10, 8:45AM CDT
Investors will remain focused on Kite's (KITE) progress with its pipeline.
HSKA: 43.41 (+0.86), CBM: 50.45 (-1.96), KITE: 57.03 (+0.40), AMGN: 174.16 (+2.13)
Arena's (ARNA) Q1 Loss Narrower but Revenues Fall Short
Arpita Dutt - Zacks Investment Research - Tue May 10, 7:27AM CDT
Sales of Arena's (ARNA) obesity treatment, Belviq, remain lackluster.
HSKA: 43.41 (+0.86), CBM: 50.45 (-1.96), ANIP: 61.06 (+0.46), ARNA: 1.68 (+0.01)
Juno (JUNO) Posts Wider Loss in Q1, Focus on Pipeline
Arpita Dutt - Zacks Investment Research - Tue May 10, 6:15AM CDT
Even though Juno's (JUNO) Q1 loss was wider-than-expected, investor focus will remain on the company's pipeline progress.
HSKA: 43.41 (+0.86), CBM: 50.45 (-1.96), JUNO: 30.86 (-0.07), CELG: 114.69 (+2.50)
Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast
PR Newswire - Mon May 09, 12:00PM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 43.41 (+0.86)
New Strong Buy Stocks for May 5th
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:13AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
MEP: 8.27 (unch), HSKA: 43.41 (+0.86), ANF: 20.71 (unch), MCHP: 55.81 (+0.17), LPLA: 25.90 (-1.05)
Heska tops Street 1Q forecasts
Automated Insights - Tue May 03, 8:08AM CDT
LOVELAND, Colo. (AP) _ Heska Corp. (HSKA) on Tuesday reported first-quarter net income of $1.2 million.
HSKA: 43.41 (+0.86)